Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Cancer Res. 2014 Jan 1;74(1):263–271. doi: 10.1158/0008-5472.CAN-13-1436

Figure 4. Absence of CD22 in lung cancer cells from patients.

Figure 4

Immunostaining performed on serial sections of lung squamous cell carcinoma shows pan cytokeratin 5/6/18 positive cancer cells (A) and CD22 positive lymphocytes (B). Immunostaining performed on serial sections of lung adenocarcinoma shows thyroid transcription factor-1 positive cancer cells (C) and CD22 positive lymphocytes (D). Scale bars = 40 µm.